Skip to main content
SpringerLink
Log in

Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Theories on the neurochemical etiology for hepatic encephalopathy have recently focussed on activation of inhibitory neurotransmitter GABA systems. Modulators of the GABAA receptor complex, including diazepam binding inhibitor, are significantly and selectively altered in hepatic encephalopathy. In animals and humans, benzodiazepine receptor antagonists rapidly ameliorate this syndrome suggesting the possible existence of an endogenous benzodiazepine-like substance. Endogenous GABAergic modulators may contribute to the neurochemical pathogenesis of hepatic encephalopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fraser, C. L., and Arief, A. I. 1985. Hepatic Encephalopathy. New Engl J Med 313:865–873.

    PubMed  Google Scholar 

  2. Jones, E. A., and Gammal, S. H. 1988. Hepatic Encephalopathy. Pages 985–1005, in (eds.) Arias, I. M., Jakoby, W. B., Popper, H., Schachter, D., Shafritz, D. A.. The Liver: Biology and Pathobiology, Second Edition Raven Press Ltd., New York.

    Google Scholar 

  3. Jones, E. A., and Schafer, D. F. 1982. Fulminent hepatic failure. InHepatology, 2nd ed.; W. B. Saunders, New York, 415–445.

    Google Scholar 

  4. Adams, R. D., and Foley, J. M. 1953. The Neurological Disorder Associated with Liver Disease. In Metabolic and Toxic Diseases of the Nervous System, Association for Research and Nervous and Mental Disease; 32:198–231.

  5. Pappas, S. C., and Jones, E. A. 1983. Methods for assessing hepatic encephalopathy. Seminars Liver Disease 3:298–307.

    Google Scholar 

  6. Zieve, L. 1987. Hepatic Encephalopathy in the Book: Pages 925–948, Schiss, O., and Schiff, E. R. (eds.)in Diseases of The Liver. JB Lippincott Co., Philadelphia.

    Google Scholar 

  7. Lockwood, A. H. 1987. Hepatic Encephalopathy: Experimental Approaches to Human Metabolic Encephalopathy. CRC Critical Reviews in Neurobiology, Vol. III. 105–133.

    Google Scholar 

  8. Hsia, Y. E. 1974. Inherited Hyperammonemic Syndromes. Gastroenterology 67:347–374.

    PubMed  Google Scholar 

  9. Jones, E. A., and Schafer, D. F. 1986. Hepatic encephalopathy: a neurochemical disorder. Prog. in Liver Disease 8:525–540.

    Google Scholar 

  10. Gilon, E., Szeinberg, A., Tauman, G., and Bodonyi, E. 1959. Glutamine Estimation in Cerebral Spinal Fluid in Cases of Liver Cirrhosis and Hepatic Coma. J Lab and Clin Med 53:714–719.

    Google Scholar 

  11. Hourami, B. T., Hamlin, E. M., and Reynolds, T. B. 1971. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy. Arch. Int. Med. 127:1033–1036.

    Google Scholar 

  12. Plum, F., and Hindfelt, B. 1976. The Neurological Complications of Liver Disease. Pages 349–377,in Vinken, P. H., Bruyn, G. W. (eds.) Handbook of Clinical Neurology. Vol. 27, Metabolic and Deficiency Diseases of the Nervous System, Part 1, Amer Elsevier, New York.

    Google Scholar 

  13. Rothstein, J. D., and Herlong, H.F. 1989. Neurological manifestations of hepatic disease. Neurologic Clinics 7:563–578.

    PubMed  Google Scholar 

  14. Bansky, G., Meier, P. J., Zeigler, W. H., Walser, H., Schmid, M., and Huber, M. 1985. Reversal of hepatic coma by benzodiazepine antagonist (RO 15-1788). Lancet June 8,:1324–1325.

    Google Scholar 

  15. Baraldi, M., Zeneroli, M. L., Ventura, E. et al. 1984. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: Reversal by a benzodiazepine antagonist. Clin Sci. 67:167–175.

    PubMed  Google Scholar 

  16. Bassett, M. L., Mullen, K. D., Skolnick, P., and Jones, E. A. 1987. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology; 93:1069–77.

    PubMed  Google Scholar 

  17. Scollo-Lavizzari G. 1985. Reversal of hepatic coma by benzodiazepine antagonist (RO 15-1788). Lancet June 8, 1:1324.

    Google Scholar 

  18. Scollo-Lavizzari, G. 1983. First clinical investigation of the benzodiazepine antagonist RO 15-1788 in comatose patients. Eur. Neurol. 22:7–11.

    PubMed  Google Scholar 

  19. Baraldi, M., and Zeneroli, M. 1982. Experimental hepatic encephalopathy: changes in the binding of Γ-aminobutyric acid. Science 216:427–428.

    PubMed  Google Scholar 

  20. Pappas, S. C. 1984. Increased gamma-aminobutyric acid (GABA) receptors in the brain precedes hepatic encephalopathy in fulminant hepatic failure. Hepatology 4:1051.

    Google Scholar 

  21. Schafer, D. F., Fowler, J. M., Munson, P. J. et al. 1983. Gammaamino butyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J Lab Clin Med 102:870–880.

    PubMed  Google Scholar 

  22. Maddison, J. E., Dodd, P. R., Morrison, M., Johnston, G. A. R., and Farrell, G. C. 1987. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology 7:621–628.

    PubMed  Google Scholar 

  23. Maddison, J. E., Dodd, P. R., Johnston, G. A. R., and Farrell, G. C. 1987. Brain Γ-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma Γ-aminobutyric acid-like activity. Gastroenterology 932:1062–1068.

    Google Scholar 

  24. Zieve, L., Ferenci, P., Rzepczynski, Ebner, J., and Ziummerman, C. H. 1986. Benzodiazepine antagonist does not alter course of experimental hepatic encephalopathy or neuronal GABA receptor affinity or density. Hepatology 6:1142.

    Google Scholar 

  25. Schafer, D. F., Pappas, S. C., Brody, L. E., Jacobs, R., and Jones, E. A. 1984. Visual Evoked potentials in a rabbit model of hepatic encephalopathy. Gastroenterology 86:540–545.

    PubMed  Google Scholar 

  26. Smilowski, A. 1978. The effect of intrahippocampal administration of τ-aminobutyric acid. In: F. Fonnom, ed. Amino acids as chemical transmitters. New York: Plenum Press, 177–180.

    Google Scholar 

  27. Gammal, S. H., Geller, D., Skolnick, P., Paul, S. M., Lisker-Melman, M., and Jones, E. A. 1987. Unequivocal amerlioration of hepatic encephalopathy by benzodiazepine receptor antagonists in a rat model of fulminant hepatic failure. J. Hepatol. 4:S17.

    Google Scholar 

  28. Ferenci, P., Grimm, G., Meryn, S., and Gangl, A. 1989. Successfull long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil. Gastroent. 96:240–243.

    Google Scholar 

  29. Grimm, G., Ferenci, P., Katzenschlager, R., Madi, C., Schneeweiss, B., Laggner, A. N., Lenz, K., and Gangl, A. 1988. Improvement of hepatic encephalopathy treated with flumazenil. Lancet i:1392–1394.

    Google Scholar 

  30. Lugaresi, E., Medori, R., Montagna, P., Baruzzi, A., Lugaresi, A., Tinuper, P., Zucconi, M., and Gambetti, P. 1986. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New Engl. J. Med. 315:997–1003.

    PubMed  Google Scholar 

  31. Basile, A. S., Gammal, S. H., Mullen, K. D., Jones, E. A., and Skolnick, P. 1988. Differential responsiveness of cerebellar purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J. Neuroscience 8:2414–2421.

    Google Scholar 

  32. Mullen, K. D., Mendelson, W. B., Martin, J. V., et al. 1988. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet i:457–459.

    Google Scholar 

  33. Barbaccia, M. L., Guameri, P., Berkovich, A., Wambebe, C., Guidotti, A., and Costa, E. 1989. The endogenous modulator of GABAA receptors in affective disorders. Pages 125–130,in E. Costa and E. Barnard, (eds.), The allosteric modulation of amino acid receptors and its therapeutic implications. New York: Raven Press.

    Google Scholar 

  34. Guidotti, A., Forchetti, C., Corda, A., Konkel, D., Bennett, C. D., and Costa, E. 1983. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonist action on benzodiazepine receptors. Proc. Natl. Acad. Sci. 80:3531–3535.

    PubMed  Google Scholar 

  35. Ferrarese, C., Alho, H., Guidotti, A., and Costa, E. 1987. Colocalization and co-release of GABA and putative allosteric modulators of GABA receptors. Neuropharm. 26:1011–1018.

    Google Scholar 

  36. Ferrero, P., Conti-Tronconi, B. M., and Guidotti, A. 1986. DBI: an anxiogenic neuropeptide found in human brain. Adv Biochem Pharmacol. 41:177–185.

    Google Scholar 

  37. Guidotti, A., Alho, H., Slobodyansky, E., and Berkovich, A., Wambebe, C. 1989. DBI processing: allosteric modulation at different GABA/benzodiazepine receptor subtypes. In: E. Costa and E. Barnard, eds. The allosteric modulation of amino acid receptors and its therapeutic implications. New York: Raven Press, 109–123.

    Google Scholar 

  38. Bormann, J., Ferrero, P., Guidotti, A., and Costa, E. 1985. Neuropeptide modulation of GABA receptor Cl channels. Regulatory Peptides 264:33–38.

    Google Scholar 

  39. Costa, E., and Guidotti, A. 1987. Neuropeptides as cotransmitters: modulatory effects at GABAergic synapses. Pages 425–435,in Meltzer, H. Y. (ed.) Psychopharmacology: the third generation of progress. Raven Press, New York.

    Google Scholar 

  40. Rothstein, J. D., McKhann, G., Guarneri, P., Barbaccia, M. L., Guidotti, A., Costa, E. 1989. Hepatic encephalopathy and cerebrospinal fluid content of diazepam binding inhibitor (DBI). Annals of Neurology Annals of Neurology 26:57–62.

    Google Scholar 

  41. DeBlas, A. L. and Sotelo, C. 1987. Localization of Benzodiazepine-like molecules in the rat brain. A light and electron microscopy immunocytochemistry study with an antibenzodiazepine monoclonal antibody. Brain Res. 413:285–296.

    PubMed  Google Scholar 

  42. DeBlas, A. L., Park, D., and Friedrich, P. 1987. Endogenous benzodiazepine-like molecules in human, rat and bovine brains studied with a monoclonal antibody to benzodiazepines. Brain Res. 413:275–284.

    PubMed  Google Scholar 

  43. Deckert, J., Kuhn, W., and Przuntek, H. 1984. Endogenous benzodiazepine ligands in human cerebrospinal fluid. Peptides 5:641–644.

    PubMed  Google Scholar 

  44. Sangameswaran, L., Fales, H. M., Friedrich, P., et al. 1986. Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. Proc. Natl. Acad. Sci. USA 83:9236–9240.

    PubMed  Google Scholar 

  45. Wildmann, J., Niemann, J., and Matthai, H. 1986. Endogenous benzodiazepine receptor agonist in human and mammalian plasma. J. Neural. Transm. 66:151–160.

    PubMed  Google Scholar 

  46. Wildmann, J., and Ranalder, U. 1988. Presence of lorazepam in the blood plasma of drug free rats. Life Sci. 43:1257–1260.

    PubMed  Google Scholar 

  47. Luckner, M. 1984. Secondary metabolism in microorganisms, plants and animals; 2nd ed., Springer-Verlag, Berlin, 272–276.

    Google Scholar 

  48. Wildmann, J., Möhler, H., Vetter, W., et al. 1987. Diazepam and N-desmethyl-diazepam are found in rat brain and adrenal and may be of plant origin. J. Neural. Transm. 70:383–398.

    PubMed  Google Scholar 

  49. Wildmann, J., Vetter, W., Ranalder, U. B., Schmidt, K., Maurer, R., Mohler, H., 1988. Occurence of pharmacologically active benzodiazepines in trace amounts in wheat and potato. Biochem. Pharm. 37:3549–3559.

    PubMed  Google Scholar 

  50. Olasmaa, M., Guidotti, A., Costa, E., Rothstein, J. D., Goldman, M. E., Weber, R. J., Paul, S. M. 1989. Endogenous benzodiazepines in hepatic encephalopathy. Lancet 1:491–492.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Johns Hopkins University, 600 North Wolfe Street, 21205, Baltimore, MD

    Jeffrey D. Rothstein

  2. FIDIA Georgetown Institute for the Neurosciences, 20007, Washington DC

    Marjut Olasmaa

Authors
  1. Jeffrey D. Rothstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marjut Olasmaa
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Special issue dedicated to Dr. Erminio Costa

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rothstein, J.D., Olasmaa, M. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy. Neurochem Res 15, 193–197 (1990). https://doi.org/10.1007/BF00972209

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00972209

Key Words

Search

Navigation